Efficacy of Immune Checkpoint Inhibitors in Metastatic Melanoma (MM) Patients with Concurrent Chronic Lymphocytic Leukemia (CLL)

被引：0
|
作者：
Guerra, Veronica [1 ]
Ologun, Gabriel [2 ]
Haydu, Lauren [2 ]
Keung, Emily [2 ]
Burton, Elizabeth [2 ]
Tawbi, Hussein [3 ]
Davis, Michael [3 ]
Wargo, Jennifer [2 ]
Ferrajoli, Alessandra [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2020年 / 20卷
关键词：
chronic lymphocytic leukemia; CLL; melanoma; immune checkpoint inhibitors; nivolumab; ipilimumab; pembrolizumab;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CLL-229
引用
收藏
页码：S225 / S225
页数：1
相关论文
共 50 条
  • [31] Immune Prognostic Index as a predictor of survival in patients with metastatic melanoma treated with immune checkpoint inhibitors
    Stukalin, Igor
    Suo, Aleksi
    Vallerand, Isabelle A.
    Lewinson, Ryan
    Heng, Daniel Y. C.
    Bebb, D. Gwyn
    Morris, Don G.
    Cheng, Tina
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB100 - AB100
  • [32] Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL)
    Shanafelt, Tait D.
    Parikh, Sameer A.
    Noseworthy, Peter A.
    Goede, Valentin
    Chaffee, Kari G.
    Bahlo, Jasmin
    Call, Timothy G.
    Schwager, Susan M.
    Ding, Wei
    Eichhorst, Barbara
    Fischer, Kirsten
    Leis, Jose F.
    Chanan-Khan, Asher Alban
    Hallek, Michael
    Slager, Susan L.
    Kay, Neil E.
    LEUKEMIA & LYMPHOMA, 2017, 58 (07) : 1630 - 1639
  • [33] Atrial Fibrillation in Patients with Chronic Lymphocytic Leukemia (CLL)
    Shanafelt, Tait D.
    Chaffee, Kari G.
    Call, Timothy G.
    Parikh, Sameer A.
    Schwager, Susan M.
    Ding, Wei
    Leis, Jose F.
    Chanan-Khan, Asher
    Slager, Susan L.
    Kay, Neil E.
    BLOOD, 2015, 126 (23)
  • [34] SECOND NEOPLASIA IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
    MOAYERI, H
    HAN, T
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1974, 15 (MAR): : 163 - 163
  • [35] Renal Disease In Patients With Chronic Lymphocytic Leukemia (CLL)
    Shanafelt, Tait D.
    Rabe, Kari G.
    Hanson, Curtis A.
    Call, Timothy G.
    Schwager, Susan
    Parikh, Sameer A.
    Nasr, Samih H.
    Leung, Nelson
    BLOOD, 2013, 122 (21)
  • [36] Cost of chronic lymphocytic leukemia (CLL) in medicare patients
    Danese, M.
    Gleeson, M.
    Reyes, C.
    Pao, M.
    Knopf, K.
    ANNALS OF ONCOLOGY, 2008, 19 : 206 - 206
  • [37] Cost of chronic lymphocytic leukemia (CLL) in Medicare patients
    Danese, M.
    Gleeson, M.
    Reyes, C.
    Pao, M.
    Knopf, K. B.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [38] Evaluation of TTV replication as a biomarker of immune checkpoint inhibitors efficacy in melanoma patients
    Pescarmona, Remi
    Mouton, William
    Walzer, Thierry
    Dalle, Stephane
    Eberhardt, Anais
    Brengel-Pesce, Karen
    Villard, Marine
    Lombard, Christine
    Trouillet-Assant, Sophie
    Viel, Sebastien
    PLOS ONE, 2021, 16 (08):
  • [39] Cardiovascular Immunotoxicity Associated with Immune Checkpoint Inhibitors in Metastatic Melanoma
    L'Orphelin, Jean-Matthieu
    Dollalille, Charles
    Akroun, Julia
    Alexandre, Joachim
    Dompmartin, Anne
    CANCERS, 2023, 15 (07)
  • [40] Immune checkpoint inhibitors in melanoma in the metastatic, neoadjuvant, and adjuvant setting
    Herrscher, Hugo
    Robert, Caroline
    CURRENT OPINION IN ONCOLOGY, 2020, 32 (02) : 106 - 113
12345